SCHEMBL531230

SCHEMBL531230

C/C=C/CC/C=C/C[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL531231 1.00
SCHEMBL4623657 0.83 TSHR (0.37)
SCHEMBL1293140 0.83 TSHR (0.37)
SCHEMBL1293139 0.83 TSHR (0.37)
SCHEMBL4623652 0.83 TSHR (0.37)
SCHEMBL17748854 0.83 TSHR (0.37)
SCHEMBL2369464 0.81 FAAH (0.40)
SCHEMBL7289512 0.81 PPARG (0.31)
SCHEMBL7289510 0.81 PPARG (0.31)
SCHEMBL29475612 0.81 FAAH (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1854877-B1 Process for the deacylation of cyclic lipopeptides ASTELLAS PHARMA INC (JP) 2012-02-08 EP disclosed
EP-2172546-A1 Process for the deacylation of cyclic lipopeptides Astellas Pharma Inc. (JP) 2010-04-07 EP disclosed
EP-0885957-B1 PROCESS FOR THE DEACYLATION OF CYCLIC LIPOPEPTIDES ASTELLAS PHARMA INC (JP) 2009-08-12 EP disclosed
EP-1854877-A2 Process for the deacylation of cyclic lipopeptides Astellas Pharma Inc. (JP) 2007-11-14 EP disclosed
EP-1666587-A1 Cyclic lipopeptide acylase Astellas Pharma Inc. (JP) 2006-06-07 EP disclosed
US-6573084-B1 Culture of Streptomyces anulatus 4811 (FERM BP-5808); deacylation of the lipid acyl moiety of FR-901379, Echinocandin B, and Aculeacin A FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-03 US disclosed
US-6537789-B1 Using isolated acylase enzyme obtained from Streptomyces FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-03-25 US disclosed
US-6399567-B1 POLYPEPTIDE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-04 US disclosed
US-6207434-B1 EFFICIENT STREPTOMYCES ACYLASE FOR PRODUCTION OF CYCLIC PEPTIDES FROM SUBSTANCE FR901379 ANALOGS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed
US-6146872-A FROM OIDIODENDRON SPECIES NO. 30084 (FERM BP-5943); EFFICIENT DEACYLATION FUKISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-11-14 US disclosed
WO-1998022498-A1 CYCLIC HEXAPEPTIDES HAVING ANTIBIOTIC ACTIVITY FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-05-28 WO disclosed
US-5693750-A MICROBIOCIDAL ACTION AGAINST PNEUMOCYSTIS INFECTIONS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-12-02 US disclosed
US-H1638-H CYCLIC HEXAPEPTIDE FURUTA TAKAHISA (JP) 1997-03-04 US disclosed
US-5569646-A TREATMENT OF PNEUMONIA; MICROBIOCIDES, FUNGICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-29 US disclosed
EP-0462531-B1 Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain FUJISAWA PHARMACEUTICAL CO (JP) 1996-10-02 EP disclosed
EP-0729974-A1 Cyclic polypeptide with antibiotic activity and a process for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-09-04 EP disclosed
EP-0644199-A1 Cyclic antimicrobial peptides and preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1995-03-22 EP disclosed
US-5376634-A Microbiocides FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-12-27 US disclosed
EP-0486011-A2 Pharmaceutical composition against Pneumocystis carinii FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-05-20 EP disclosed
EP-0462531-A2 Cyclic polypeptide with antibiotic activity, process for its preparation and pure culture of a Coelomycetes strain FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-12-27 EP disclosed